Vaccine experts report positive results on Phase 1 trial of personalized vaccine for lymphoplasmacytic lymphoma
A team of researchers from City of Hope and The University of Texas M.D. Anderson Cancer Center has reported safety and ...
The Brighterside of News on MSN6d
First-ever mRNA vaccine halts pancreatic cancer in its tracks
RNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...
Buy Rating for Evaxion Biotech Supported by Strong Clinical Results and PIONEER Platform’s Potential
H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price ...
The American Journal of Managed Care3d
Can Vaccines Be Developed for MPNs? Study Examines the Challenges
Researchers from Bulgaria conduct an analysis of the potential for therapeutic vaccines in by comparing testing results for ...
pharmaphorum2d
Job losses loom at Achilles as TIL therapy platform is cut
Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...
Medical Xpress1mon
Targeting cancer with precision: Neoantigen vaccines show promise
The drive to achieve precision in targeting cancer's Achilles heel without harming healthy tissue is propelling the exploration of neoantigen vaccines. The Cell Biotechnology Laboratory and ...
Achilles climbs after decision to find strategic alternatives
Achilles Therapeutics (ACHL) stock surges as company announces plans to explore strategic alternatives. Read more here.
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know
Shares of Achilles Therapeutics plc (NASDAQ: ACHL) are surging following a major strategic announcement from the company. The ...
City of Hope Vaccine Experts Report Positive Results on Phase 1 Trial of Personalized Vaccine for Lymphoplasmacytic Lymphoma
A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in ...
Morningstar2d
City of Hope Vaccine Experts Report Positive Results on Phase 1 Trial of Personalized Vaccine for Lymphoplasmacytic Lymphoma
The team is also exploring additional therapies to pair with the neoantigen for more vaccine efficacy. Dr. Kwak is a paid consultant with Renhaim Inc. The neoantigen vaccine research builds upon ...